Clinical Research Directory
Browse clinical research sites, groups, and studies.
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
Sponsor: University Hospital, Bordeaux
Summary
This study proposes to describe and evaluate the rate of spontaneous regression of CIN2 at 2 year of follow up in women between 18 and 39 year old. This follow-up is proposed as an alternative to the treatment of reference (conization) with a possible extension to 4 years
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2019-08-23
Completion Date
2029-09-01
Last Updated
2025-02-10
Healthy Volunteers
No
Conditions
Interventions
abstention from CIN2 treatment and surveillance for at least 2 years
Non-interventional monocentric prospective study taking place at the Bordeaux University Hospital where women with a CIN2 meeting the eligibility criteria will benefit from abstention from treatment and surveillance for at least 2 years
Locations (1)
CHU Bordeaux
Bordeaux, France